Masthead
 

Custom Search
ADVERTISEMENT
Today's Health Photos
SEOUL (Reuters) - South Korea has suspended imports of U.S. poultry and poultry products because of an outbreak of bird flu in the United States, the Agriculture Ministry said in a statement on Sunday.

BAMAKO (Reuters) - The United Nations mission to fight Ebola should be wound down quickly once the battle is won, U.N. Secretary General Ban Ki-moon said on Saturday during his first tour of countries stricken with the virus.

(Reuters) - A child being monitored for Ebola in a Chicago hospital has been discharged after testing negative for the virus, the state health agency said on Saturday.

GENEVA (Reuters) - The death toll from Ebola in the three worst-affected countries in West Africa has risen to 7,373 among 19,031 cases known to date there, the World Health Organization said on Saturday.

(Reuters) - An American nurse who was exposed to Ebola while volunteering in Sierra Leone was released from the National Institutes of Health's Clinical Center in Maryland on Friday without showing signs of the disease, NIH said.

HASTINGS, Sierra Leone (Reuters) - U.N. Secretary General Ban Ki-moon on Friday praised healthcare workers fighting the Ebola virus as he paid his first visit to Liberia and Sierra Leone following an outbreak that has killed nearly 7,000 people.

(Reuters) - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Solvadi from Gilead Sciences.

CHICAGO (Reuters) - A child who arrived in Chicago with a fever was under observation on Friday at a city hospital to rule out the Ebola virus, hospital officials said.

(Reuters) - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, providing the first competition for Gilead Sciences huge selling and expensive medicine for the liver-destroying virus.

(Reuters) - Cubist Pharmaceutical Inc's drug to treat complicated urinary tract and intra-abdominal infections won U.S. approval on Friday, highlighting the regulator's interest in tackling the growing threat of the so-called superbugs.

ADVERTISEMENT
Log into your Thames Valley Portal
Video
loading